Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Frazier & Co. Moves Into Technology Investing

This article was originally published in Start Up

Executive Summary

Frazier & Co.'s recent launch of Frazier Technology Ventures (FTV), a new technology fund that will apportion part of its portfolio to e-health/bioinformatic companies seems, at first blush, to come at a bit of an odd time. The volatility of the tech sector has many VCs reexamining their positions in that arena, with e-health financings particularly hard hit. Frazier & Co.'s move is also contrary to the general trend of VC firms choosing to specialize in either e-health or traditional health care investing. A number of health care firms, like Oak, Sequoia and Accel dropped health care entirely last year during the e-health boom. And Brentwood Ventures spun out separate IT and health care groups. But, according to Frazier & Co.'s management, their timing was just right and reflects both patience and careful planning. Moreover, they emphasize that the new fund, while within the Frazier & Company infrastructure, will, in fact, be invested independently by a group of Information Technology specialists.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090257

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel